0
Skip to Content
Health Business Group
Growth Strategy
Due Diligence for Transactions
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Consultants
Case Studies
History
Testimonials
Podcast
Media Room
blog
Contact
Health Business Group
Growth Strategy
Due Diligence for Transactions
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Consultants
Case Studies
History
Testimonials
Podcast
Media Room
blog
Contact
Folder: Services ▾
Back
Growth Strategy
Due Diligence for Transactions
Folder: Sectors ▾
Back
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Folder: About ▾
Back
Consultants
Case Studies
History
Testimonials
Podcast
Media Room
blog
Contact
Pharma 8/20/07 Pharma 8/20/07

Once a year treatment for osteoporosis

Read More
Economics, Pharma 8/20/07 Economics, Pharma 8/20/07

Struggling to keep up with Wal-Mart

Read More
Medical travel/medical..., Pharma, Research 8/15/07 Medical travel/medical..., Pharma, Research 8/15/07

Some people think it's funny...

Read More
Economics, Pharma 8/9/07 Economics, Pharma 8/9/07

If you can't take the heat, get out of Wal-Mart's way

Read More
Economics, Pharma 8/6/07 Economics, Pharma 8/6/07

Free antibiotics at Publix

Read More
Pharma, Policy and politics 7/18/07 Pharma, Policy and politics 7/18/07

Bashing big pharma on epilepsy drugs

Read More
Economics, Pharma, Physicians 7/16/07 Economics, Pharma, Physicians 7/16/07

Are Bexxar and Zevalin really held hostage by "market forces"?

Read More
Patients, Pharma 6/28/07 Patients, Pharma 6/28/07

Information shortage

Read More
Economics, Pharma, Policy and politics 6/24/07 Economics, Pharma, Policy and politics 6/24/07

Not unreasonable

Read More
Pharma 6/13/07 Pharma 6/13/07

Is a big pharma LBO on the horizon?

Read More
Pharma 6/11/07 Pharma 6/11/07

OTC dangers

Read More
Pharma, Policy and politics 6/6/07 Pharma, Policy and politics 6/6/07

The outspoken Genentech CEO, Arthur Levinson

Read More
International, Pharma 6/4/07 International, Pharma 6/4/07

No miracle

Read More
International, Pharma 5/30/07 International, Pharma 5/30/07

Hand in the cookie jar, head in the noose

Read More
Economics, Patients, Pharma 5/22/07 Economics, Patients, Pharma 5/22/07

Wal-Mart's $4 generics having an impact

Read More
Entrepreneurs, Pharma, Research, Technology 5/20/07 Entrepreneurs, Pharma, Research, Technology 5/20/07

Interview with Mike Totterman, iCardiac's Chairman and CEO (transcript)

Read More
Pharma, Policy and politics 5/15/07 Pharma, Policy and politics 5/15/07

OxyContin, OxyMorons and OxyApologists

Read More
e-health, Pharma 5/13/07 e-health, Pharma 5/13/07

Interview with Donato Tramuto, Physicians Interactive (transcript)

Read More
Pharma, Policy and politics 5/11/07 Pharma, Policy and politics 5/11/07

Rantasorous Rx

Read More
Entrepreneurs, Pharma, Podcast, Research, Technology 5/10/07 Entrepreneurs, Pharma, Podcast, Research, Technology 5/10/07

Podcast interview with Mike Totterman, Chairman and CEO of iCardiac Technologies

Read More
Newer Posts
Older Posts

SERVICES

Growth StrategyDue Diligence for Transactions

SECTORS

Tech-enabled Healthcare Services
Life Sciences

Digital Health and Health IT
Private Equity/Investors

ABOUT

Consultants
Case Studies
History
Testimonials

Media Room
Blog
Contact

101 Federal St., S. 1900 | Boston, MA 02110 | (617) 731-3182

© 2026 Health Business Group. All Rights Reserved.